05.11.15
Global sales revenues of the Hartmann Group rose by 5.7% to €475.6 million ($530.8 million) in the first quarter of 2015 compared to the previous year. The organic growth, excluding exchange-rate and acquisition effects, was 5.1%.
In the Wound Management segment, Hartmann recorded an increase in sales revenues of 7.2% to €101.2 million ($113 million) in the first quarter of 2015. Sales in modern wound care products and HydroTherapy, the innovative treatment concept for hard-to-heal wounds, provided strong impetus for growth. The sales performance of the negative-pressure wound therapy system offered under the Vivano brand and of postoperative dressings and traditional dressing materials was also positive.
In the Incontinence Management segment, sales revenues reached €159.2 million ($177.7 million), an increase of 4.2%. MoliCare Mobile, the incontinence pants for mobile people, and Menalind professional, the skin-care range for irritated, mature skin, were growth drivers.
Sales in the Infection Management segment improved by 7.8% to €117.4 million ($131 million). The company says it achieved especially good growth in the product categories surgical sets, surgical draping sets and disposable surgical instruments as well as hand and surface disinfection.
The share of the medical core segments out of total sales was 79.5% as of March 31, 2015.
Other Group Activities recorded sales revenues of €97.8 million ($109.2 million) in the first quarter of 2015, an increase of 4.1% compared to the previous year.
Sales growth of the Hartmann Group had a positive effect on earnings in the first three months of fiscal year 2015. The extensive expansion of marketing and sales activities in all business segments and the continued high price pressure from customers impacted results negatively.
Despite a difficult market environment, the Hartmann Group increased EBIT and consolidated net income. EBIT increased by 7.1% to €35.6 million ($39.7 million) as of March 31, 2015. Consolidated net income increased by 5.4% to €22.7 million ($25.3 million) compared to the previous year.
In the Wound Management segment, Hartmann recorded an increase in sales revenues of 7.2% to €101.2 million ($113 million) in the first quarter of 2015. Sales in modern wound care products and HydroTherapy, the innovative treatment concept for hard-to-heal wounds, provided strong impetus for growth. The sales performance of the negative-pressure wound therapy system offered under the Vivano brand and of postoperative dressings and traditional dressing materials was also positive.
In the Incontinence Management segment, sales revenues reached €159.2 million ($177.7 million), an increase of 4.2%. MoliCare Mobile, the incontinence pants for mobile people, and Menalind professional, the skin-care range for irritated, mature skin, were growth drivers.
Sales in the Infection Management segment improved by 7.8% to €117.4 million ($131 million). The company says it achieved especially good growth in the product categories surgical sets, surgical draping sets and disposable surgical instruments as well as hand and surface disinfection.
The share of the medical core segments out of total sales was 79.5% as of March 31, 2015.
Other Group Activities recorded sales revenues of €97.8 million ($109.2 million) in the first quarter of 2015, an increase of 4.1% compared to the previous year.
Sales growth of the Hartmann Group had a positive effect on earnings in the first three months of fiscal year 2015. The extensive expansion of marketing and sales activities in all business segments and the continued high price pressure from customers impacted results negatively.
Despite a difficult market environment, the Hartmann Group increased EBIT and consolidated net income. EBIT increased by 7.1% to €35.6 million ($39.7 million) as of March 31, 2015. Consolidated net income increased by 5.4% to €22.7 million ($25.3 million) compared to the previous year.